{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-006520","form_type":"8-K","ticker":null,"cik":"0001173281","company_name":"NeuBase Therapeutics, Inc.","filed_at":"2023-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.141951+00:00","generated_at":"2026-06-16T18:28:18.030440+00:00","sec_items":["5.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"NeuBase Therapeutics changes fiscal year-end from Sept 30 to Dec 31 effective 2023","bullets":["Board approved change on April 21, 2023, aligning fiscal year with calendar year.","Fiscal year beginning Jan 1, 2023 will end Dec 31, 2023; transitional 10-QT for Oct-Dec 2022.","Reason: better alignment with the Company's planning cycles."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-006520","json":"https://secwatch.observer/filing/0001558370-23-006520.json","markdown":"https://secwatch.observer/filing/0001558370-23-006520.md","text":"https://secwatch.observer/filing/0001558370-23-006520.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173281/000155837023006520/0001558370-23-006520-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173281/000155837023006520/tmb-20230421x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T18:28:18.030440+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c1f3c634440f2918fed98f3c68525d4c85f6d728","claim":"NeuBase Therapeutics, Inc.: Changed fiscal year end from September 30 to December 31, effective for the year ending December 31, 2023 (effective 2023-12-31).","evidence_excerpt":"On April 21, 2023, the Board of Directors (the “Board”) of NeuBase Therapeutics, Inc. (the “Company”) approved a change in the Company’s fiscal year from the twelve months beginning October 1 and ending September 30 to the twelve months beginning January 1 and ending December 31, which will be effective for the year ending December 31, 2023.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173281/000155837023006520/0001558370-23-006520-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"fiscal year change"},{"label":"Effective","value":"2023-12-31"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}